ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMUX Immunic Inc

1.18
-0.05 (-4.07%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -4.07% 1.18 14:00:11
Open Price Low Price High Price Close Price Previous Close
1.22 1.18 1.24 1.19 1.23
more quote information »

Recent News

Date Time Source Heading
13/6/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202406:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/6/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
28/5/202420:30PRNUSImmunic to Participate in Industry and Scientific..
25/5/202406:06EDGAR2Form S-3/A - Registration statement under Securities Act of..
08/5/202421:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202420:45EDGAR2Form 8-K - Current report
08/5/202420:30PRNUSImmunic, Inc. Reports First Quarter 2024 Financial Results..
06/5/202420:30PRNUSImmunic to Participate in Investor and Scientific..
01/5/202420:30PRNUSImmunic, Inc. to Announce Financial Results for the First..
30/4/202420:30PRNUSImmunic Announces Publication of Extended Data From Phase 2..
04/4/202421:30PRNUSImmunic to Host MS R&D Day and Participate in Investor..
20/3/202421:30PRNUSImmunic Receives Notice of Allowance for..
09/3/202408:05EDGAR2Form 8-K - Current report
07/3/202422:30PRNUSImmunic to Participate in Investor and Scientific..
07/3/202413:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202413:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:30PRNUSImmunic Presents Data From Phase 2 CALLIPER and CALVID-1..
22/2/202422:38EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:35EDGAR2Form 8-K - Current report
22/2/202422:30PRNUSImmunic, Inc. Reports Year End 2023 Financial Results and..
15/2/202422:30PRNUSImmunic, Inc. to Announce Financial Results for the Year..
15/2/202408:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202400:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:36EDGAR2Form S-3 - Registration statement under Securities Act of..
06/2/202400:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/2/202422:30PRNUSImmunic to Participate in Investor and Scientific..
25/1/202409:05EDGAR2Form PRE 14A - Other preliminary proxy statements
20/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202408:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/1/202401:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202422:41EDGAR2Form 8-K - Current report
05/1/202422:35PRNUSImmunic Highlights 2023 Accomplishments and Upcoming..
05/1/202422:30PRNUSImmunic, Inc. Announces Private Placement of up to $240..
22/12/202300:30EDGAR2Form 8-K - Current report
23/11/202308:20EDGAR2Form S-3 - Registration statement under Securities Act of..
21/11/202322:30PRNUSImmunic Receives Notice of Allowance for United States..
14/11/202322:38EDGAR2Form 8-K - Current report
14/11/202322:30PRNUSImmunic, Inc. Reports Third Quarter 2023 Financial Results..
07/11/202322:30PRNUSImmunic to Announce Financial Results for the Third Quarter..

Your Recent History

Delayed Upgrade Clock